Allarity Therapeutics (Nasdaq: ALLR) is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. The company is leveraging its proprietary, highly accurate Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes. Publicly traded on NASDAQ, Allarity (ALLR) is headquartered in Boston, MA, while maintaining an R&D facility in Hoersholm, Denmark. Allarity is committed to enhancing patient outcomes through improved decision-making and personalized cancer care.


Pharmaceutical

Allarity Therapeutics

Thomas Jensen

Bruce Pratt

Steen Knudsen

Marie Foegh

Joan Brown

Ulrik Christensen

Leadership Team

CEO and Executive Team

Board of Directors

Allarity Therapeutics

Org chart

Teams

Leadership Team

CEO and Executive Team

Board of Directors

Discover similar companies